Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Treatment Resistant Depression

Recent news which mentions Treatment Resistant Depression

Building Australia's Psychedelics Industry: A New Joint Venture And Why It's Important
Tags Cannabis Psychedelics Markets
From Benzinga
atai Life Sciences' Drug Trial For Depression Fails To Deliver Expected Results, Stock Plunges
Tickers ATAI
Tags Psychedelics Markets Cannabis
From Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
Tickers ATAI AWKNF CMND CMPS
Tags FDA MYCOF Legal
From Benzinga
Phase 2 Trial For This Psychedelic, Potential Treatment For Severe Depression
Tags Treatment Resistant Depression Market News 5/MeO/DMT
From Benzinga
Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial
Tickers BMNDF
Tags DMT Clinical Trial Cannabis Markets
From Benzinga
Atai's Phase 2 Study For Treatment-Resistant Depression Completes Enrollment, Expects Results Soon
Tickers ATAI
Tags Small Cap Benzinga Perception Neuroscience
From Benzinga
GH Research Shares Q2 2022 Financial Results & Business Updates
Tickers GHRS
Tags Management GHRS News
From Benzinga
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
Tickers ATAI HTGC
Tags Michael Dutra Srinivas Rao Cannabis
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.